MIRA INFORM REPORT

 

 

Report Date :

04.07.2014

 

IDENTIFICATION DETAILS

 

Name :

COREY ORGANICS PRIVATE LIMITED (w.e.f. 06.07.2009)

 

 

Formerly Known As :

COREY ORGANICS LIMITED

 

 

Registered Office :

100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500038, Telangana

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

01.03.1996

 

 

Com. Reg. No.:

01-023399

 

 

Capital Investment / Paid-up Capital :

Rs. 30.429 Millions

 

 

CIN No.:

[Company Identification No.]

U23231TG1996PTC023399

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDC00743B

 

 

PAN No.:

[Permanent Account No.]

AABCC3624L

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Fine Chemicals and Drug Intermediates.

 

 

No. of Employees :

300 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (15)

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

The company seems to have weak financial risk profile as the rating takes into consideration the delays by the company in servicing its debt oblitgations, the delays are because of the companys weak liquidity on account of its working capital intensive operations.

 

However, business is active. Payment terms are reported to be slow.

 

The company can be considered for business dealings on a secured trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

The economy grew 4.7 %in 2013/14, marking a second straight year of sub-5 % growth – the worst slowdown in more than a quarter of a century. The data was below an official estimate of 4.9 % annual growth and compared with 4.5 % in the last fiscal year. However, the current account deficit narrowed sharply to $ 32.4 billion at 1.7 % of gross domestic product, in 2013/14 from a record high of $ 98.8 billion or 4.7 %, the year before.A sharp fall in gold imports due to restrictions on overseas purchases and muted import of capital goods helped shrink the current account deficit.

 

Online retailer Flipkart has acquired fashion portal Myntra as it prepares to battle with the rapidly expanding India arm of the global e-commerce giant Amazon. The company raised $ 210 million from Russian Investment firm DST Global which has also invested in companies like Facebook, Twitter and Alibaba Group.

 

General Motors will start exporting vehicles from its Talegaon plant near Pune in the second half of 2014. GM was one of the few global carmakers that was using its India plant only for the domestic market.

 

Google has overtaken Apple as the world’s top brand in terms of value, according to global market research agency Millward Brown. Google’s brand value shot up 40 % in a year to $ 158.84 billion. The top 10 of the 100 slots were dominated by US companies.

 

Infosys lost another heavy weight when B G Srinivas, a board member put in his papers. He is the third CEO-hopeful to quit after Chairman N R Narayana Murthy’s return to the company – Ashok Vemuri and V Balakrishnan being the other two.While Vemuri went on to lead IGate, Balakrishnan joined politics.

 

Naresh Goyal – promoted Jet Airways posted biggest quarterly loss – Rs 2153.37 crore – in the three months ended March 31, mainly because it has been offering discounts to passengers to fill planes.

 

William S Pinckney – Chairman and CEO of Amway India was arrested by the Andhra Pradesh Police in connection with a complaint against the direct selling firm. This is the second time that he has been taken into custody. A year, ago the Kerala Police had arrested Pinckney and two company directors on charges of financial irregularities.

 

China has told its state-owned enterprises to sever links with American consulting firms after the United States charged five Chinese military officers wih hacking US companies. China’s action which targets consultancies like McKinsey & Co. and the Boston Consulting Group, sterns from fears that the first are providing trade secrets to the US governments.

 

India has emerged as a country with some of the highest unregistered businesses in the world. Indonesia has the maximum number of shadow businesses, says a study of 68 countries by Imperial College Business School in London.

 

Pfizer has abandoned its attempt to buy AstraZeneca for nearly $ 118 billion after the latter refused an offer of 55 pounds a share.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long term rating: “D”

Rating Explanation

The company is in default or expected to be in default soon.

Date

23.04.2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Ms. Lavanya

Designation :

Accounts Executive

Contact No.:

91-40-23715528

Date :

03.07.2014

 

 

LOCATIONS

 

Registered Office :

100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500038, Telangana, India

Tel. No. :

91-40-23715528

Fax No. :

91-40-23701738 

E-Mail :

coreyorganics@gmail.com

finance@coreyorganics.com

info@chavadipharma.com

info@coreyorganics.com

coreyfinance@gmail.com

Website :

www.chavadipharma.com

Location :

Owned

Locality :

Commercial

 

 

Factory 1 :

Shed No.1 & Plot No. 23,  IDA Kothur, Kothur (V&M),  Mahaboobnagar (District)  Anhdra Pradesh, India

Tel. No. :

91-8548-256246

Fax No. :

91-8548-256246

 

 

Factory 2 :

Plot No. 35, Road No : 01, Jawahar Lal Nehru Pharma City, Parawada, Vishakapatnam, Anhdra Pradesh, India

 

 

DIRECTORS

 

As on 30.09.2013

 

Name :

Devi Reddy Raja Kumar Reddy

Designation :

Managing Director

Address :

H. No. 100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500038, Andhra Pradesh, India

Date of Birth/Age :

20.08.1956

Date of Appointment :

01.03.1996

DIN No. :

00059112

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U23231TG1996PTC023399

COREY ORGANICS Private LIMITED

Managing director

01/04/2006

01/03/1996

Active

NO

2

U24110TG1996PTC023074

SRI CHAVADI PHARMA PRIVATE LIMITED

Managing director

06/09/2013

30/09/2005

Active

NO

 

 

Name :

Mr. Devereddy Vidna Reddy

Designation :

Director

Address :

100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500038, Andhra Pradesh, India

Date of Birth/Age :

27.04.1986

Date of Appointment :

30.09.2005

DIN No. :

00065644

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U23231TG1996PTC023399

COREY ORGANICS PRIVATE LIMITED

Director

30/09/2005

30/09/2005

Active

NO

2

U24232TG2010PTC068382

SAI SREYAS PHARMACEUTICAL PRIVATE LIMITED

Additional director

15/12/2011

15/12/2011

Active

NO

 

 

Name :

Mr. Vijayakumar Reddy Devireddi

Designation :

Director

Address :

4/468-2 Up Star, Vivekananda Nagar, Kadapa – 516001, Andhra Pradesh, India

Date of Birth/Age :

01.06.1950

Date of Appointment :

30.09.1999

DIN No. :

02653753

 

 

Name :

Deepna Devireddy

Designation :

Director

Address :

100/2RT, Sanjeeva Reddy Nagar, Hyderabad – 500038, Andhra Pradesh, India 

Date of Birth/Age :

19.02.1989

Date of Appointment :

10.02.2011

DIN No. :

03245840

 

 

KEY EXECUTIVES

 

Name :

Ms. Lavanya

Designation :

Accounts Executive

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2013

 

Names of Shareholders

No. of Shares

Percentage of Holding

D. Rajakumar Reddy 

304285

10.00

D. Sailaja

304066

9.99

C. Giridhar Reddy

219

0.01

R.Sai Pradeep Reddy

398553

13.10

D. Deepna

818587

26.90

D. Vidna

597440

19.63

B. Dileep Kumar Reddy

592500

19.47

B. Saraswathi

27200

0.89

Total

3042850

100.00

 

 

As on 30.09.2013

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Fine Chemicals and Drug Intermediates.

 

 

Exports :

 

Products :

Finished goods

Countries :

·         Pakistan

Germany

USA

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

GENERAL INFORMATION

 

Suppliers :

Zhejiang Medicines and Health Products, China

 

 

Customers :

Euticals, USA

 

 

No. of Employees :

300 (Approximately)

 

 

Bankers :

State Bank of Hyderabad, 11602, 1st Floor, MJR Complex, NH-7, Shamshabad, SSI Branch, Ranga Reddy District, Hyderabad - 501218, Andhra Pradesh, India

 

 

Facilities :

SECURED LOANS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

LONG TERM BORROWINGS

 

 

Term Loans from SBH

16.634

23.464

Loan from APSFC

5.496

7.619

Loan from LIC of India

2.250

2.250

Vehicle Loan from Sundram Finane

0.153

0.398

 

 

 

SHORT TERM BORROWINGS

 

 

Loans repayable on demand from banks

 

 

Working capital loan from SBH

92.148

77.012

Total

116.681

110.743

 

NOTE

 

LONG TERM BORROWINGS

 

Loan from LIC of India is sactioned against Keymen Insurance Policy and secured by the said policy.

 

Term loans from APSFC and SBH is secured by Hypothecation of Stocks, Receivables and collateral security of Factory Land and Buildings, Plant and Machinery and further secured by personal guarantees of Directors of the company.

 

 

SHORT TERM BORROWINGS

 

Working capital loan from State Bank of Hyderabad is secured by Hypothecation of Stocks, Book Debtors and Receivables and collateral security of Factory Land, Shed, Plant and Machinery and further secured by personal guarantee of Directors of the company.

 

Banking Relations :

--

 

 

Financial Institution:

Andhra Pradesh State Financial Corporation, 5-9-194, Chirag Ali Lane, P.B. No. 165, Hyderabad - 500001, Andhra Pradesh, India

 

 

Auditors :

 

Name :

Suryachandra and Associates

Chartered Accountants

Address :

H.No: 8-3-315/8,Plot No:10,Maruthi Nagar, Hyderabad – 500045, Andhra Pradesh, India

Tel. No. :

91-40-23752728

Fax No. :

91-40-23752829

Income-tax PAN of auditor or auditor's firm :

ACFFS1012D

 

 

Associates :

·         Sri Chavadi Pharma Private Limited

Sri Gandi Anjaneya Ice Plant

 

 

CAPITAL STRUCTURE

 

As on 30.09.2013

 

Authorised Capital : Rs. 50.000 Millions

 

Issued, Subscribed & Paid-up Capital : Rs. 45.000 Millions

 

 

As on 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3,500,000

Equity Shares

Rs.10/- each

Rs. 35.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

3,042,850

Equity Shares

Rs.10/- each

Rs. 30.429 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

30.429

24.840

21.739

(b) Reserves & Surplus

21.228

17.224

15.320

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

51.657

42.064

37.059

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

43.649

53.245

40.530

(b) Deferred tax liabilities (Net)

0.043

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

43.692

53.245

40.530

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

92.148

77.012

37.356

(b) Trade payables

67.350

57.614

60.805

(c) Other current liabilities

6.722

6.410

3.166

(d) Short-term provisions

1.210

1.560

4.332

Total Current Liabilities (4)

167.430

142.596

105.659

 

 

 

 

TOTAL

262.779

237.905

183.248

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

86.409

97.108

50.967

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

19.849

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.304

0.979

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

86.409

97.412

71.795

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

104.485

76.139

42.495

(c) Trade receivables

48.098

37.156

44.284

(d) Cash and cash equivalents

7.283

4.090

4.398

(e) Short-term loans and advances

16.504

23.108

20.276

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

176.370

140.493

111.453

 

 

 

 

TOTAL

262.779

237.905

183.248

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Revenue from Operations

264.774

244.606

211.359

 

 

Other Income

0.570

1.719

0.790

 

 

TOTAL                                     (A)

265.344

246.325

212.149

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

159.184

144.492

128.783

 

 

Changes in inventories and Work-in-progress

(34.753)

(14.508)

(7.832)

 

 

Employee benefits

21.676

16.925

10.810

 

 

Other expenses

79.365

70.707

54.863

 

 

Preoperative expenses written off

0.000

0.000

0.103

 

 

TOTAL                                     (B)

225.472

217.616

186.727

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

39.872

28.709

25.422

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

21.236

17.237

9.137

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

18.636

11.472

16.285

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

13.065

7.332

7.116

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)                 (G)            

5.571

4.140

9.169

 

 

 

 

 

Less

TAX                                                                  (H)

1.567

2.236

3.070

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX (G-H)                  (I)

4.004

1.904

6.099

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

28.899

35.477

9.767

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

1.32

0.77

2.81

 

Particulars

 

 

 

31.03.2014

 

 

 

 

Sales Turnover (Approximately)

 

 

360.000

 

 

 

 

 

The above information has been parted by Mr. Lavanya (Accounts Executive).

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

1.51

0.77

2.87

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

2.10

1.69

4.34

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

2.12

1.74

5.65

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.11

0.10

0.25

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

2.63

3.10

2.10

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.05

0.99

1.05

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

21.739

24.840

30.429

Reserves & Surplus

15.320

17.224

21.228

Net worth

37.059

42.064

51.657

 

 

 

 

Long-term borrowings

40.530

53.245

43.649

Short term borrowings

37.356

77.012

92.148

Total borrowings

77.886

130.257

135.797

Debt/Equity ratio

2.102

3.097

2.629

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

211.359

244.606

264.774

 

 

15.730

8.245

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

211.359

244.606

264.774

Profit

6.099

1.904

4.004

 

2.89%

0.78%

1.51%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

Yes

18]

Major customers

Yes

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10244607

07/09/2010

10,000,000.00

ANDHRA PRADESH STATE FINANCIAL CORPORATION

5-9-194, CHIRAG ALI LANE, P.B. NO : 165, HYDERABAD - 500001, ANDHRA PRADESH, INDIA

A95442778

2

90134483

06/08/2004 *

1,350,000.00

STATE BANK OF HYDERABAD

SSI BRANCH, SHAMSHMARD, HYDERABAD, ANDHRA PRADESH, INDIA

-

3

90133934

20/04/2013 *

143,500,000.00

STATE BANK OF HYDERABAD

11 60 2, 1ST FLOOR, MJR COMPLEX, NH-7, SHAMSHABAD,
SSI BRANCH, RANGA REDDY DISTRICT, HYDERABAD - 501218, ANDHRA PRADESH, INDIA

B73389652

 

* Date of charge modification

 

 

UNSECURED LOANS

 

PARTICULAR

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

LONG TERM BORROWINGS

 

 

From Banks and Financial Institutions

7.202

15.343

Loans and advances from related parties

 

 

From Directors and Share Holders

11.914

4.171

Total

19.116

19.514

 

 

CHANGE OF ADDRESS

 

The registered office of the company has been shifted from Shed No.1, IDA Kottur, Andhra Pradesh, India to the present address w.e.f. 29.07.2010.

 

 

GENERAL INFORMATION

 

The company is engaged in the business of Manufacturing of Bulk Drugs and Intermediates.

 

 

FINANCIAL PERFORMANCE

 

During the year 2012-13, the company has achieved a turnover of Rs. 265.344 Millions and earned a net profit of Rs. 5.571 Millions.

 

During the current financial year 2013-14 the results will be good and more encouraging than the previous year.

 

 

CONTINGENT LIABILITIES:

 

PARTICULARS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

 

 

 

Outstanding Bank Guarantees

1.615

1.410

 

 

 

 

 

FIXED ASSETS

 

·         Land

Building

Plant and Machinery

Furniture and Fixtures

Lab Equipments

Electrical Equipments

Office Equipment/ Computers

Pollution Maintenance Equipment

Vehicles

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.59.72

UK Pound

1

Rs.102.45

Euro

1

Rs.81.54

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLK

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

MRI

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

2

OPERATING SCALE

1~10

2

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

2

--LEVERAGE

1~10

2

--RESERVES

1~10

--

--CREDIT LINES

1~10

--

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

15

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.